Genmab A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Genmab A/S generated cash of $7,380,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$606,000,000 last year. Net change in cash is therefore $4,974,000,000.
Cash Flow
| 2014 | 132.67M | -1.01B | 1.03B |
|---|---|---|---|
| 2015 | 311.44M | -480.88M | 643.09M |
| 2016 | 327.71M | -1.01B | 91.18M |
| 2017 | 1.58B | -667.57M | 214.91M |
| 2018 | 1.01B | -1.77B | -70.90M |
| 2019 | 1.32B | -1.98B | 3.66B |
| 2020 | 6.43B | -2.35B | 71M |
| 2021 | 2.22B | -961M | -420M |
| 2022 | 3.91B | -2.76B | -789M |
| 2023 | 7.38B | -1.28B | -606M |
GMAB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.89B | 8.95B | 7.26B | 3.55B | 533M | 1.34B | 307.02M | 873.98M | 359.08M | 168.13M |
Operating activities | ||||||||||
Net income | 5.63B | 7.03B | 3.98B | 5.90B | 2.85B | 1.61B | 1.06B | 1.13B | 757.52M | 297.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 295M | 362M | 248M | 259M | 139M | 87.59M | 69.75M | 40.95M | 31.82M | 12.33M |
Stock-based compensation expense | 586M | 439M | 310M | 200M | 147M | 0 | 75.98M | 53.18M | 36.56M | 27.71M |
| Deferred income tax benefit | 586M | 439M | 310M | 200M | 147M | 0 | 75.98M | 53.18M | 36.56M | 27.71M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 797M | -2.12B | -1.07B | 306M | -1.65B | 0 | 270.35M | 0 | -89.95M | 0 |
Inventories | -57M | 0 | 0 | -474M | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 622M | 283M | 304M | 168M | 440M | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 7.38B | 3.91B | 2.22B | 6.43B | 1.32B | 1.01B | 1.58B | 327.71M | 311.44M | 132.67M |
Investing activities | ||||||||||
Purchases Of Investments | -10.90B | -9.69B | -15.61B | -12.41B | -5.81B | -3.52B | -3.42B | -3.00B | -2.07B | -2.67B |
Investments In Property Plant And Equipment | -376M | -317M | -252M | -307M | -111M | -477.36M | -88.51M | -33.10M | -135.38M | -75.44M |
Acquisitions Net | 0 | 2.44B | 709M | 2.04B | 32M | 405.67M | 0 | 20.85M | 125.94M | 63.25M |
Cash generated by investing activities | -1.28B | -2.76B | -961M | -2.35B | -1.98B | -1.77B | -667.57M | -1.01B | -480.88M | -1.01B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 135M | 140M | 3.87B | 312K | 836K | 819K | 2.56M | 998.2M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -564M | -908M | -447M | -25M | 0 | -146.17M | 0 | -118.09M | 0 | 0 |
Repayments of term debt | -91M | -73M | -58M | -44M | -31M | 0 | 0 | -118K | -237K | -2.12M |
Cash used in financing activities | -606M | -789M | -420M | 71M | 3.66B | -70.90M | 214.91M | 91.18M | 643.09M | 1.03B |
Net Change In Cash | 4.97B | 936M | 1.69B | 3.70B | 3.01B | -814.63M | 1.04B | -566.96M | 514.89M | 190.95M |
Cash at end of period | 14.86B | 9.89B | 8.95B | 7.26B | 3.55B | 532.90M | 1.34B | 307.02M | 873.98M | 359.08M |
| Data source | Data source | Data source | Data source | Data source |